BSE · ASTONEALAB
ASTONEA LABS LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,062
of 5,004 stocks
🏆 New peak
▲ 201W
Peak #2,062 · 01 Oct 2026
ASTONEA LABS LIMITED, a microcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, is growing revenue at a solid clip, and remains firmly promoter-controlled, with promoters holding 72%.
Market Cap
365.94 Cr
P/E Ratio
77.54
P/B Ratio
—
ROE
—
ROCE
11.34%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q4 2025-26 | Q4 2024-25 | Q3 2024-25 |
|---|---|---|---|
| Revenue | 81.29 Cr | 27.93 Cr | 22.00 Cr |
| Net Profit | 3.10 Cr | 1.25 Cr | 1.97 Cr |
| EPS | 3.08 | — | — |
| Operating Profit | 5.15 Cr | 2.64 Cr | 3.64 Cr |
Shareholding pattern
Promoter
72.30%
Public
27.70%
PUBLIC BREAKDOWN
FII
0.00%
DII
0.07%
MF (within DII)
0.00%
Individuals
22.32%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.